NFKB1 and metabolic disease: More importantly, NF-κB was further implicated in pathological conditions and diseases, including inflammation, cancer, metabolic disorders, and skeletal disparities, prompting the design of NF-κB based relevant therapeutic modalities3, 4, 5.